GlassScriptPhysician profile
Travis G Obrien
NPI 1124466222
$3,259.57
in general payments reported to CMS, 2019-2025
13 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $852 · 2021: $701 · 2022: $634 · 2023: $285 · 2024: $76.20 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354 · Travel and Lodging: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.81 |
| Travel and Lodging | $131.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $798.00 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Medtronic USA, INC. | $568.33 | 2019-2020 | |
| Abbott Laboratories | $525.28 | 2019-2022 | |
| Boston Scientific Corporation | $520.21 | 2019-2022 | |
| Spr Therapeutics, INC | $473.52 | 2021-2024 | Sprint Pns System |
| Nevro Corp. | $107.57 | 2021-2022 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Relievant Medsystems, INC. | $63.87 | 2021 | |
| Biotronik Nro, INC. | $31.74 | 2025 | Prospera |
| Lilly USA, LLC | $28.01 | 2021-2022 | |
| Bioventus LLC | $20.36 | 2019 | |
| Collegium Pharmaceutical, INC. | $16.44 | 2019 | |
| Itamar Medical INC | $13.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Obrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.